Articles with public access mandates - George DalekosLearn more
Not available anywhere: 7
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase
CFM Perez, MH Harms, KD Lindor, HR Van Buuren, GM Hirschfield, ...
Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020
Mandates: Canadian Institutes of Health Research, National Institute for Health …
The challenges of primary biliary cholangitis: What is new and what needs to be done
BT Beretta-Piccoli, G Mieli-Vergani, D Vergani, JM Vierling, D Adams, ...
Journal of autoimmunity 105, 102328, 2019
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
EJ Giamarellos-Bourboulis, A Siampanos, A Bolanou, S Doulou, ...
The Lancet Respiratory Medicine 12 (4), 294-304, 2024
Mandates: European Commission
HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL
E Kyriazopoulou, GN Dalekos, S Metallidis, G Poulakou, IC Papanikolaou, ...
Shock 61 (3), 395-399, 2024
Mandates: European Commission
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
CFM Perez, A Gerussi, PJ Trivedi, C Corpechot, AJ Van Der Meer, ...
European journal of gastroenterology & hepatology 35 (1), 112-119, 2023
Mandates: Government of Italy
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool
CFM Perez, A Gulamhusein, M Carbone, PJ Trivedi, AJ Van Der Meer, ...
European journal of gastroenterology & hepatology 33 (1S), e266-e273, 2021
Mandates: Government of Italy
Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation
E Kranidioti, I Ricaño-Ponce, N Antonakos, E Kyriazopoulou, A Kotsaki, ...
Critical Care Medicine, 10.1097, 2024
Mandates: Netherlands Organisation for Scientific Research, European Commission
Available somewhere: 56
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
HSA Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal ...
New England Journal of Medicine 384 (12), 1113-1124, 2021
Mandates: National Institute for Health Research, UK
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ...
European journal of preventive cardiology 28 (11), 1279-1289, 2021
Mandates: Netherlands Organisation for Scientific Research, British Heart Foundation …
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
Mandates: US National Institutes of Health, German Research Foundation, National …
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ...
Nature medicine 27 (10), 1752-1760, 2021
Mandates: Netherlands Organisation for Scientific Research, European Commission
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ...
Nature genetics 45 (6), 670-675, 2013
Mandates: US National Institutes of Health, German Research Foundation, UK Medical …
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
HL Tillmann, J Hadem, L Leifeld, K Zachou, A Canbay, C Eisenbach, ...
Journal of viral hepatitis 13 (4), 256-263, 2006
Mandates: German Research Foundation
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ...
Journal of hepatology 73 (6), 1368-1378, 2020
Mandates: National Natural Science Foundation of China, Cancer Research UK, UK Medical …
An open label trial of anakinra to prevent respiratory failure in COVID-19
E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ...
Elife 10, e66125, 2021
Mandates: European Commission
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
E Kyriazopoulou, T Huet, G Cavalli, A Gori, M Kyprianou, P Pickkers, ...
The Lancet Rheumatology 3 (10), e690-e697, 2021
Mandates: European Commission, European & Developing Countries Clinical Trials Partnership
Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: the Hepatitis Delta International Network (HDIN)
A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ...
Liver International 38 (5), 842-850, 2018
Mandates: Helmholtz Association
Expert clinical management of autoimmune hepatitis in the real world
R Liberal, YS de Boer, RJ Andrade, G Bouma, GN Dalekos, A Floreani, ...
Alimentary pharmacology & therapeutics 45 (5), 723-732, 2017
Mandates: National Institute for Health Research, UK
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
C Efe, AV Kulkarni, BT Beretta‐Piccoli, B Magro, A Stättermayer, ...
Hepatology 76 (6), 1576-1586, 2022
Mandates: US National Institutes of Health
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
S Pape, RJ Snijders, TJG Gevers, O Chazouilleres, GN Dalekos, ...
Journal of hepatology 76 (4), 841-849, 2022
Mandates: National Institute for Health Research, UK
Publication and funding information is determined automatically by a computer program